Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Goldshield Group PLC

Latest From Goldshield Group PLC

Niche pharma empire-building Cinven clinches Amdipharm and Mercury deals for £832m

The European private equity firm Cinven has acquired family-owned niche pharmaceuticals company Amdipharm of the UK for £367 million, and is planning to merge it with Mercury Pharma (formerly Goldshield Group), which it bought for £465 million last month. The two companies' combined revenues are around £250 million, and EBITA is £100 million.

Cardiovascular Metabolic Disorders

Cinven's Mercury Pharma Buy Could Spur European Specialty Consolidation

Cinven’s $730 million acquisition of the U.K.-based specialty company Mercury Pharma could act as a platform to consolidate the sector in Europe, suggests the private equity company.

BioPharmaceutical Europe

Fuhrer family pulls out of Goldshield bidding following latest management offer

Goldshield's management appears to have trumped the Fuhrer family and former Goldshield CEO Ajit Patel in the battle for control of Goldshield Group with a bid valuing the UK firm at £178 million and the support of a large contingent of its shareholders.

Goldshield management team outbids Fuhrer family

Goldshield Group's management team has launched a counter-bid for the UK listed pharmaceuticals and consumer health group, offering a 2.2% premium to last week's offer from the family that owns Israel's Neopharm. The management team's bidding vehicle, Midas Bidco, is offering 460 pence per share in cash, valuing Goldshield at £169 million.

Israel Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Goldshield Group PLC
  • Senior Management
  • Ajit Patel, Managing Dir.
  • Contact Info
  • Goldshield Group PLC
    Phone: (44) 81684366
    Bensham House, 324 Bensham Lane
    Thornton Heath, CR7-7EQ